Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velaglucerase Alfa in Japanese Gaucher Disease Patients
NCT01614574Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of velaglucerase alfa in Gaucher disease (GD), sponsored by Takeda. Started Mar 2012; status: completed.
02
Drugs
velaglucerase alfa
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on NCT01614574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614574.